Skip to content

MDMA: all studies

Page 131 of 346: studies 1,301 to 1,310 of 3,454, newest first. Back to the MDMA overview

Research

Cannabis and Ecstasy/MDMA: Empirical Measures of Creativity in Recreational Users

Journal of Psychoactive Drugs December 1, 2009 Katy A. Jones, Mark Blagrove, A. C. Parrott 41 citations

This study investigated the associations between chronic cannabis and Ecstasy/MDMA use and one objective and two subjective measure of creativity. Fifteen abstinent Ecstasy users, 15 abstinent cannabis users, and 15 nondrug-user controls, completed three measures of creativity: the Consequences behavioral test of creativity, self-assessed performance on the Consequences test, and Gough's Trait...

Effects of 3,4‐methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity

Journal of Neurochemistry November 30, 2009 Dominik K. Biezonski, Jerrold S. Meyer 47 citations

J. Neurochem. (2009) 112 , 951–962. Abstract 3,4‐Methylenedioxymethamphetamine (MDMA; ‘Ecstasy’) is a popular recreational drug used worldwide. This study aimed to determine the effects of this compound on the expression of nerve terminal serotonergic markers in rats. Experiment 1 investigated MDMA‐induced changes in levels of the serotonin transporter (SERT) and the vesicular monoamine...

Role of Serotonin via 5-HT2B Receptors in the Reinforcing Effects of MDMA in Mice

PLoS One November 20, 2009 Stéphane Doly, Jesus Bertran‐gonzalez, Jacques Callebert et al. 80 citations

The amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) reverses dopamine and serotonin transporters to produce efflux of dopamine and serotonin, respectively, in regions of the brain that have been implicated in reward. However, the role of serotonin/dopamine interactions in the behavioral effects of MDMA remains unclear. We previously showed that MDMA-induced locomotion,...

A fatal case of myocardial damage due to misuse of the "designer drug" MDMA.

Legal medicine (Tokyo, Japan) November 2009 Rie Sano, Toshikazu Hasuike, Minoru Nakano et al.

A 39-year-old woman collapsed after oral intake of 3,4-methylenedioxymethyl-amphetamine (MDMA, "ecstasy"). After ingestion of the drug, she had felt persistent discomfort in her anterior chest area, and lost consciousness for a few minutes on the following morning. She was transported to a hospital and died seven days after collapse. A serum sample obtained on admission revealed an MDMA...

Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat.

Drug Metabolism and Disposition November 2009 Michael H. Baumann, Dorota Zolkowska, Insook Kim et al.

Based on animal data, there is speculation that (+ or -)-3,4-methylenedioxymethamphetamine (MDMA) is neurotoxic to humans. Extrapolation of MDMA findings from animals to humans requires assessment of pharmacokinetics in various species, and low-dose administration data from rats are lacking. In this study, we examine MDMA pharmacokinetics in rats given low (2 mg/kg) and high (10 mg/kg) doses of...

Effects of acute 3,4-methylenedioxymethamphetamine on sleep and daytime sleepiness in MDMA users: a preliminary study.

Sleep November 2009 Surilla Randall, Chris‐ellyn Johanson, Manuel E. Tancer et al.

3,4-Methylenedioxymethamphetamine (MDMA) affects monoamine neurotransmitters that play a critical role in sleep and daytime alertness. However, the acute effects of MDMA on sleep and daytime sleepiness have not been studied under placebo-controlled conditions. This study was designed to establish the effects of acute MDMA or placebo administration and sleep restriction on sleep and daytime...

Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(-)-MDMA trained mice.

Journal of Pharmacology and Experimental Therapeutics November 1, 2009 Kevin S. Murnane, Naoki Murai, Leonard L. Howell et al. 34 citations

3,4-Methylenedioxymethamphetamine (MDMA) is a substituted phenethylamine more commonly known as the drug of abuse "ecstasy." The acute and persistent neurochemical effects of MDMA in the mice are distinct from those in other species. MDMA shares biological effects with both amphetamine-type stimulants and mescaline-type hallucinogens, which may be attributable to distinct effects of its two...

Learning and memory deficits in ecstasy users and their neural correlates during a face-learning task.

Brain Research October 6, 2009 Gloria M P Roberts, Liam Nestor, Hugh P Garavan

It has been consistently shown that ecstasy users display impairments in learning and memory performance. In addition, working memory processing in ecstasy users has been shown to be associated with neural alterations in hippocampal and/or cortical regions as measured by functional magnetic resonance imaging (fMRI). Using functional imaging and a face-learning task, we investigated neural...